(Q37032897)

English

Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients

scientific article published on April 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Parvin Layegh

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Zohreh Mousavi

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Donya Farrokh Tehrani

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Seyed Mohammad Reza Parizadeh

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Mohammad Khajedaluee

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

1 April 2016

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

International Journal of Reproductive Biomedicine (Yazd, Iran)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

263-270

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

29 September 2017

The metabolic syndrome in young Korean women with polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

29 September 2017

Ovarian and adrenal hyperandrogenism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

29 September 2017

Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

29 September 2017

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

29 September 2017

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

29 September 2017

Characterization of the insulin resistance of aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

29 September 2017

Mechanisms of Insulin Resistance in Aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

29 September 2017

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

27 June 2018

Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

27 June 2018

Insulin resistance and advancing age: what role for dehydroepiandrosterone sulfate?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

27 June 2018

Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

27 June 2018

Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

27 June 2018

Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

27 June 2018

Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

27 June 2018

Insulin resistance in nonobese patients with polycystic ovarian disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

27 June 2018

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

27 June 2018

Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Adrenal androgen excess and body mass index in polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Clinical, hormonal and metabolic characteristics of polycystic ovary syndrome among obese and nonobese women in the Croatian population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Screening women with polycystic ovary syndrome for metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

A relationship between dehydroepiandrosterone sulphate and insulin resistance in obese men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4918775

4 September 2018

Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism

1 reference

https://pubmed.ncbi.nlm.nih.gov/27351028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/27351028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27351028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study on clinical and sonographic features in obese and nonobese patients with polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27351028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27351028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenal androgen excess in hyperandrogenism: relation to age and body mass

1 reference

https://pubmed.ncbi.nlm.nih.gov/27351028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic Effects of Dehydroepiandrosterone (DHEA) in Diabetic Mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/27351028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/27351028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenal androgen excess and body mass index in polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27351028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37032897&oldid=2103758126"